Pharmaceutical package
Latest Sterling Drug, Inc. Patents:
- Nuclease resistant compounds
- Carpet cleaning composition with bleach
- Method of inhibiting mammalian topoisomerase II and malignant cell growth in mammals, with substituted (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4 ]-benzoxazine(and-benzothiazine)-6-carboxylic acids
- Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
- Multiply substituted anilines, phenols and pyridines-immunomodulating agents
Description
FIG. 1 is a front elevational view of a pharmaceutical package, showing my new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a side elevation as viewed from the right in FIG. 1;
FIG. 4 is an enlarged cross-sectional view taken along line 4--4 of FIG. 1;
FIG. 5 is an enlarged cross-sectional view taken along line 5--5 of FIG. 1; and
FIG. 6 is an enlarged cross-sectional view taken along line 6--6 of FIG. 1.
Referenced Cited
U.S. Patent Documents
D218878 | October 1970 | Dubbels |
2366886 | January 1945 | Van Tuyl |
3494322 | February 1970 | Dubbels |
3759371 | September 1973 | Marks |
Patent History
Patent number: D263559
Type: Grant
Filed: Apr 2, 1979
Date of Patent: Mar 30, 1982
Assignee: Sterling Drug, Inc. (New York, NY)
Inventor: Albert C. G. Poore (New Malden)
Primary Examiner: Robert C. Spangler
Law Firm: Wenderoth, Lind & Ponack
Application Number: 6/26,233
Type: Grant
Filed: Apr 2, 1979
Date of Patent: Mar 30, 1982
Assignee: Sterling Drug, Inc. (New York, NY)
Inventor: Albert C. G. Poore (New Malden)
Primary Examiner: Robert C. Spangler
Law Firm: Wenderoth, Lind & Ponack
Application Number: 6/26,233
Classifications
Current U.S. Class:
D/9337;
D/9339;
D/9341;
D/9415
International Classification: D0903;
International Classification: D0903;